scispace - formally typeset
J

Joseph Abecassis

Researcher at University of Strasbourg

Publications -  55
Citations -  3319

Joseph Abecassis is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Cancer. The author has an hindex of 27, co-authored 55 publications receiving 3167 citations.

Papers
More filters
Journal ArticleDOI

The collagenase gene family in humans consists of at least four members.

TL;DR: It is concluded that the collagenase gene family in humans consists of at least four members, and speculate that expression of these genes plays a role in cancer.
Journal ArticleDOI

Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.

TL;DR: This study reports the first large-scale gene expression analysis of a unique HNSCC location, the hypopharynx, and identifies 164 differentially expressed genes potentially involved in the acquisition of metastatic potential.
Journal Article

Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.

TL;DR: There was a highly significant positive correlation between ST3 RNA levels and local invasiveness by the cancer cells, suggesting that enhanced expression of the ST3 gene may contribute to the neoplastic phenotype in head and neck carcinomas.
Journal ArticleDOI

Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours.

TL;DR: In head and neck squamous‐cell carcinomas, over‐expression of the 2 stromelysin genes and the type‐1 collagenase gene (but not the pump‐1 gene) is associated with a high degree of tumour differentiation, suggesting that theStromelysins may be implicated in the clinical course of head and head tumours.
Journal ArticleDOI

Biological and Clinical Relevance of Transcriptionally Active Human Papillomavirus (HPV) Infection in Oropharynx Squamous Cell Carcinoma

TL;DR: Important criteria required to predict clinically active HPV infection are highlighted, new biological pathways implicated in HPV tumorigenesis are identified and the understanding of HPV‐HNSCC physiopathology is increased to develop new targets for therapy.